Buccal drug delivery

Bibliography

• TYERS M, MANN M: From genomics to proteomics. Nature (2003) 422:193–197.
   Google Scholar
• BETZ SF, BAXTER SM, FETROW JS: Function first: a powerful approach to post genomic drug discovery. DrugDiscov. Today (2002) 7:8765–871.
   Google Scholar
• MEYER JM, GINSBURG GS: The path to personalised medicine. Curr. Opin. Biol. (2002) 6:434–438.
   Google Scholar
• GURWITZ D, WIEZMAN A, REHAVI M: Teaching pharmacogenomics to prepare future physicians and researchers for personalised medicine. Trends Pharmacol Sci. (2003) 24:122–125.
   Google Scholar
• WILSON CG, WASHINGTON N: Drug delivery to the oral cavity. In: Physiological Pharmacuetics, biological barriers to drug absorption. CG W N Washington (Eds), Ellis Horwood, Chichister, UK (1989):21–36.
   Google Scholar
• SAMARANAYAKE LP, FERGUSON MM: Delivery of antifungals to the oral cavity. Adv. Drug Deliv. Rev. (1994) 13:161–179.
   Google Scholar
• HARRIS D, ROBINSON JR: Drug delivery via the mucous membranes of the oral cavity. J. Pharm. Sci. (1992) 81:1–10.
   Google Scholar
• RATHBONE MJ, DRUMMOND BK, TUCKER IG: The oral cavity as a site for systemic drug delivery. Adv. DrugDeliv. Rev. (1994) 13:1–22.
   Google Scholar
• SMART JD: Drug delivery using buccal adhesive systems. Adv. Drug Deliv. Rev. (1993) 11:253–270.
   Google Scholar
• WHEATHERELL JA, ROBINSON C, RATHBONE MJ: Site specific differences in the salivary concentrations of substances in the oral cavity - implications for the aetiology of oral disease and local drug delivery. Adv. Drug Deliv. Rev. (1994) 13:23–42.
   Google Scholar
• MCPHERSON LMD, DAWES C: Distribution of sucrose around the mouth and clearance after a sucrose mouthrinse or consumption of three different foods. Caries Res. (1994) 28:150–155.
   Google Scholar
• VIVIEN-CASTIONI N, GURNY R, BAENHI P, KALSATOS V: Salivary fluoride concentrations following applications of bioadhesive tablets and mouthrinses. Eur. j Pharm. Biopharm. (2000) 49:27–33.
   Google Scholar
• HAO J, HENG PWS: Buccal delivery systems. Drug Dev. Ind. Pharm. (2003) 29:821–832.
   Google Scholar
• EVESON JW, SCULLY C: Color atlas of oral pathology. Mosby-Wolfe, London, UK (1995).
   Google Scholar
• GHANDI RB, ROBINSON JR: Oral cavity as a site for bioadhesive drug delivery. Adv. Drug Deliv. Rev. (1994) 13:43–74
   Google Scholar
• SQUIER CA, WERTZ PW: Permeability and pathophysiology of the oral mucosa. Adv. Drug Deliv. Res. (1993) 12:13–24
   Google Scholar
• HERRARA JL, LYONS MF, JOHNSON LF: Saliva: its role in health and disease. J. Clin. Gastroenterol (1988) 10:569–578.
   Google Scholar
• SLOMIANY BL, MURTY VI,, PIOTROWSKI J, SLOMIANY A: Salivary mucins in oral mucosal defence. Gen. Pharmac. 1996; 27:761–771.
   Google Scholar
• BRADWAY SD, BERGEY EJ, JONES PC, LEVINE MJ: Oral mucosal pellicle. Biochem. J. (1989) 261:887–896.
   Google Scholar
• COLLINS LM, DAWES C: The surface area of the adult human mouth and thickness of the salivary film covering the teeth and the oral mucosa. J. Dent. Res. (1987) 66:1300–1302.
   Google Scholar
• ADDY M: Local delivery of antimicrobial agents to the oral cavity. Adv. Drug Deliv. Rev. (1994) 13:123–134.
   Google Scholar
• VEUILLEZ F, KALIA YN, JACQUES Y, DESHUSSES J, BURT P: Factors and strategies for improving buccal absorption of peptides. Eur. j Pharm. Biopharm. (2001) 51:93–109.
   Google Scholar
• •A review of the mechanism of protein/ peptide absorption in the buccal pouch, and the use of absorption enhancers to increase this. 23. KUROSAKI Y KIMURA T: Regional variation in oral mucosal drug permeability. Crit. Rev. Thera)). Drug Carrier Syst. (2000) 17:467–508.
   Google Scholar
• SQUIER CA, LESCH CA: Penetration pathways of different compounds through epidermis and oral epithelia. J. Oral Pathol (1988) 17:512–516.
   Google Scholar
• JUNGINGER H, HOOGSTRAATE J, VERHOEF J, Recent advances in buccal drug delivery and absorption-in vitro and in vivo studies./ Control. Rel. (1999) 62:149–159.
   Google Scholar
• SONG Y, WANG Y, THAKUR R, VMMICHNIAK B: Mucosal drug delivery: membranes, methodologies and applications. Crit. Rev. Therap. Drug Carrier Syst. (2004) 21:195–256.
   Google Scholar
• SHOJAEI AM: Buccal mucosa as a route for systemic drug delivery, a review. Pharm. Pharmacuet. Sci. (1998) 1:15–30.
   Google Scholar
• FLORENCE AT, ATTWOOD DA: Buccal and sublingual absorption. In: Physicochemical Principals of Pharmacy. Palgrave, Basingstoke, UK (1998):392.
   Google Scholar
• KUROSAKI Y, NISHIMURA H, TERAO K, NAKAYAMA T, KIMURA T: Existence of a specialised absorption mechanism for cefadroxil, an aminocephalosporin antibiotic, in the human oral cavity. Int. J. Pharm. (1992) 82:165–169.
   Google Scholar
• KUROSAKI Y, YANO K, KIMURA T, Perfusion cells for studying regional variation in oral mucosal permeability in humans. 2. A specialized transport mechanism in D-glucose absorption exists in dorsum of tongue. J. Pharm. Sci. (1998) 87:613–615.
   Google Scholar
• YAMAMOTO A, ISEKI T, OCHI-SUGIYAMA M, OKADA N, FUJITA T, MURANISHI S: Absorption of water-soluble compounds with different molecular weights and [Asul.7] - eel calcitonin from various mucosal administration sites J. Control. Rel. (2001) 76:363–374.
   Google Scholar
• SENEL S, HINCAL AA: Drug permeation enhancement via the buccal route: possibilities and limitations. J. Control. Rel. (2001) 72:133–144.
   Google Scholar
• MORISHITA M, BARICHELLO JM, TAKAYAMA K, CHIBA Y, TOKIWA S, NAGAI T: Pluronic F-127 gels incorporating highly purified unsaturated fatty acids for buccal delivery of insulin. Int. J. Pharm. (2001) 212:289–293.
   Google Scholar
• TSUTSUMI K, OBATA Y, NAGAI T, LOFTSSON T, TAKAYAMA K: Buccal absorption of ergotamine tartrate using the bioadhesive tablet system in guinea pigs. Int. J. Pharm. (2002) 238:161–170.
   Google Scholar
• PORTERO A. REMUNAN-LOPEZ C, NIELSEN, HM: The potential of chitosan in enhancing peptide and protein absorption across the TR146 cell culture model-an in vitro model of the buccal epithelium. Pharm. Res. (2002) 19:169–174.
   Google Scholar
• LEE J, KELLAWAY IW: Buccal permeationof ED-Ala2 D-Leu5lenkephalin from liquid crystalline phases of glyceryl monooloeate. Int. J. Pharm. (2000) 195:3538.
   Google Scholar
• NICLAZZO JA, REED BL, FINNIN BC: Modification of buccal delivery following pre-treatment with skin penetration enhancers. J. Pharm. Sci. (2004) 93(8):2054–2063.
   Google Scholar
• YAMAMOTO A, HAYAKAWA E, LEE VH: Insulin and proinsulin proteolysis in mucosal homogenates of the albino rabbit: implications in peptide drug delivery rom non-oral routes. Life Sci. (1990) 47:2465–2474.
   Google Scholar
• TAVAKOLI-SABERI MR, WILLIAMS AUDUS KL: Aminopeptidase activity in human buccal epithelium and primary cultures of hamster buccal epithelium. Pharm. Res. (1991) 6:S197.
   Google Scholar
• BURNSIDE BA, KEITH AD, SNIPES W: Microporous hollow fibres as a peptide delivery system for the buccal cavity. Proc. Int. Symp. Control. Rel. Bioact. Mater. (1989) 16:93–94.
   Google Scholar
• SMART JD: Bioaclhesion. In: Encyclopaedia of Biomaterials and Biomedical Engineering. GE W GL Bowlin (Eds), Marcel Dekker, New York, NY, USA (2004):62–71.
   Google Scholar
• •A review of the various types of medical bioadhesives.
   Google Scholar
• HARDING SE, DAVIS SS, DEACON MP, FIEBRIG I: Biopolymer mucoaclhesives. Biotechnol Genet. Eng. Revs. (1999) 6:41–85.
   Google Scholar
• LEE JW, PARK JH, ROBINSON JR: Bioadhesive-based dosage forms: the next generation. J. Pharm. Sci. (2000) 89:850–866.
   Google Scholar
• SMART JD: The basics and underlying mechanisms of mucoadhesion. Adv. Drug Deliv. Rev. (In press).
   Google Scholar
• •A review of the mechanisms of bio/ mucoadhesion.
   Google Scholar
• AHUJA A, KHAR RP, ALT J: Mucoaclhesivedrug delivery systems. Drug Dev. Ind. Pharm. (1997) 23:489–515.
   Google Scholar
• BERNKOP-SCHNURCH A. SCHOLLER S, BIEBEL RG: Development of controlled release systems based on thiolated polymers. J. Control. Rel. (2000) 66:39–48.
   Google Scholar
• BERNKOP-SCHNURCH A. KAST CE, RICHTER MF: Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine. J. Control. Rel. (2001) 71:277–285.
   Google Scholar
• BERNKOP-SCHNURCH A. CLAUSEN AE, HNATYSZYN M: Thiolated polymers, synthesis and in vitro evaluation of polymer-cysteamine conjugates. Int. J. Pharm. (2001) 226:185–194.
   Google Scholar
• KAST CE, BERNKOP-SCHNURCH A: Thiolated polymers- thiomers: development and in vitro evaluation of chitosan - thiolglycolic acid conjugates. Biomaterials (2001) 22:2345–2352.
   Google Scholar
• GUGGI D, MARSCHULTZ MK, BERNKOP-SCHNURCH A: Matrix tablets based on thiolated poly (acrylic acid): pH dependent variation in distintegration and mucoadhesion. Int. J. Pharm. (2004) 274:97–105.
   Google Scholar
• LANGOTH N, KALBE J, BERNKOP-SCHNURCH A: Development of buccal drug delivery systems based on a thiolated polymer. Int. J. Pharm. (2003) 252:141–148.
   Google Scholar
• LEITNER VM, WALKER GF, BERNKOP-SCHNURCH A: Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins. Europ. j Pharm. Biopharm. (2003) 56:207–214.
   Google Scholar
• LEE J, YOUNG SA, KELLAWAY IW: Water quantitatively induces the mucoadhesion of liquid crystalline phases of glyceryl monooleate. j Pharm. Pharmacol (2001) 53:629–636.
   Google Scholar
• SMART JD: An in vitro assessment of some mucosa-adhesive dosage forms. Int. J. Pharm. (1991) 73:69–74.
   Google Scholar
• SMART JD: Recent developments in the use of bioadhesive buccal systems for local and systemic delivery of drugs. Crit. Rev. Thera)). Drug Carrier Syst. (2004) 21(4):319–344.
   Google Scholar
• ••A review of the recent advances inbioadhesive drug delivery within the oral cavity.
   Google Scholar
• NAGAI T: Topical mucosal adhesive dosage forms. Med. Res. Rev. (1986) 6(2):227–242.
   Google Scholar
• VENUGOPALAN P, SAPRE A, VENKATESAN N, VYAS SP: Pelleted bioadhesive polymeric nanoparticles for the buccal delivery of insulin: preparation and characterization. Pharmazie (2001) 56:217–219.
   Google Scholar
• TIWARI D, GOLDMAN D, TOWN C, SAUSE R, MADAN PL: In vitro - in vivo evaluation of a controlled release buccal bioadhesive device for oral drug delivery. Pharm. Res. (1999) 16:1775–1780.
   Google Scholar
• TIWARI D, SAUSE R, MADAN PL, GOLDMAN D: Evaluation of polyoxyethylene homopolymers for buccal bioadhesive drug delivery device formulations. AAPS Pharmsci (1999) 1(3):E13.
   Google Scholar
• CHOI HG, KIM CK: Development of omeprazole buccal adhesive tablets stability enhancement in human saliva. J. Control. Rel. (2000) 68:397–404.
   Google Scholar
• IKINCI G, CAPAN Y, SENEL S, ALAADDINOGLU E, DALKARA T, HINCAL AA: In vitro in vivo studies on a buccal bioadhesive tablet formulation of carbamezepine. Pharmazie (2000) 55:762–765.
   Google Scholar
• MARTIN L, WILSON CG, KOOSHA F, TETLEY L, GRAY AL, SEVDA S, UCHEGBU IF: The release of model macromolecules may be controlled by the hydrophobicity of palmitoyl glycol chitosan hydrogels. J. Contr. Rel. (2002) 80:87–100.
   Google Scholar
• MARTIN L, WILSON CG, KOOSHA F, UCHEGBU IF: Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels. Europ. j Pharm. Biopharm. (2003) 55:35–45.
   Google Scholar
• COESSENS P, HERREBOUT F, BOEVER JA, VOORSPOELS J, REMON JP: Plaque inhibiting effect of bioadhesive mucosal tablets containing chlorhexidine in a 4-day plaque regrowth model. Clin. Oral Invest. (2002) 6:217–212.
   Google Scholar
• AMEYE D, VOORSPOELS J, FOREMAN P et al.: Ex vivo bioaclhesion and in vivo testosterone bioavailability study of different bioadhesive formulations based on starch-g-poly(acrylic acid) copolymers and starch / poly(acrylic acid) mixtures. J. Control. Rel. (2002) 79:173–182.
   Google Scholar
• GERESH S, GDALEVSKY GY, GILBOA I, VOORSPOELS J, REMON JP, KOST J: Bioadhesive grafted copolymers as platforms for peroral drug delivery: a study of theophylline release. J. Control. Rel. (2004) 94:391–399.
   Google Scholar
• JAIN AC, AUNGST BJ, ADEYEYE MC: Development and in-vitro evaluation of buccal tablets prepared using danazol-sulfobutylether 7 fl-cyclodextrin (SBE 7) complexes. J. Pharm. Sci. (2002) 91:1659–1668.
   Google Scholar
• MERKLE HP, ANDERS R, WERMERSKIRCHEN A: Mucoaclhesive buccal patches for peptide delivery. In: Bioadhesive drug delivery systems. V L R Gurny (Eds), CRC Press, Boca Raton, FL, USA (1990):105–136.
   Google Scholar
• SHOJAEI AH, PAULSON J, HONARY S: Evaluation of poly(acrylic acid-co-ethylhexyl acrylate) films for mucoadhesive transbuccal drug delivery: factors affecting the force of mucoadhesion. J. Contr. Rel. (2000) 67:223–232.
   Google Scholar
• SHARMA P, HAMSA V: Formulation andevaluation of buccal mucoadhesive patches of terbutalene sulphate. STP Pharma. Sci. (2001) 11:275–281.
   Google Scholar
• ROSSI S, SANDRI G, FERRARI F, BONFERONI MC, CARAMELLA C: Buccal delivery of acyclovir from films based on chitosan and polyacrylic acid. Pharm. Dev. Technol (2003) 8:199–208.
   Google Scholar
• NAFEE NA, ISMAIL FA, BORATE NA, MORTADA LM: Mucoaclhesive buccal patches of miconazole nitrate: in vitro/ in vivo performance and effect of ageing. Int. J. Pharm. (2003) 264:1–14.
   Google Scholar
• KOCKISCH S, REES GD, YOUNG SA, TSIBOUKLIS J, SMART JD: Polymeric microspheres for drug delivery to the oral cavity: an in vitro evaluation of mucoadhesive potential. J. Pharm. Sci. (2003) 92:1614–1623.
   Google Scholar
• KOCKISCH S, REES, YOUNG SA, TSIBOUKLIS J, SMART JD: In-situ evaluation of drug-loaded microspheres on a mucosal surface under dynamic test conditions. Int. J. Pharm. (2004) 276:51–58.
   Google Scholar
• JONES DS, IRWIN CR, WOOLFSON AD, DJOKIC J, ADAMS V: Physochemical characterisation and preliminary in vivo efficacy of bioadhesive, semisolid formulations containing flurbiprofen for the treatment of gingivitis. Pharm. Sci. (1999) 88:592–598.
   Google Scholar
• JONES DS, WOOLFSON, BROWN AF: Viscoelastic properties of bioadhesive chlorhexidine containing semisolids for topical application to the oropharynx. Pharm. Res. (1998) 15:1131–1136.
   Google Scholar
• JONES DS, LAWLOR MS, WOOLFSON AD: Rheological and mucoadhesive characterisation of polymeric systems composed of poly(methylvinylether-co-maleic anhydride) and poly(vinylpyrrolidone), designed as platforms for topical drug delivery. Pharm. Sci. (2003) 92:995–1007.
   Google Scholar
• SHIN SJ, BUM JP, CHOI JS: Enhancedbioavailability by buccal administration of triamcinolone acetonide from bioadhesive gels in rabbits. Int. J. Pharm. (2000) 209:37–43.
   Google Scholar
• PARK JS, YOON JI, LI H, MOON DC, HAN K: Buccal mucosal ulcer healing effect of rhEGF/Eudispert hv hydrogel. Arch. Pharm. Res. (2003) 26:659–665.
   Google Scholar
• PETELIN M, PAVLICA Z, BIZIMOSKA S, SENTJURC M: In vivo study of different ointments for drug delivery into oral mucosa by EPR oximetry. Int. J. Pharm. (2004) 270:83–91.
   Google Scholar
• SIGARDSSON HH, KNUDSEN E, LOFTSSON T, LEEVES N, SIGURJONSDOTTIR JF, MASSON M: Mucoadhesive sustained drug delivery system based on cationic polymer and anionic cyclodextrin / triclosan complex. J. Ind Phenom. Macrocyd Chem. (2002) 44:169–172.
   Google Scholar
• PATEL D, SMITH AW, GRIST N, BARNETT P, SMART JD: In-vitro mucosal model predictive of bioadhesive agents in the oral cavity. J. Control. Rel. (1999) 61:175–183.
   Google Scholar
• PATEL D, SMITH JR, SMITH AW, GRIST NW, BARNETT P, SMART JD: An atomic force microscopy investigation of bioadhesive polymer adsorption onto human buccal cells. Int. J. Pharm. (2000) 200:271–277.
   Google Scholar
• KOCKISCH S, REES GD, YOUNG SA, TSIBOUKLIS J, SMART JD: A direct-staining method to evaluate the mucoadhesion of polymers from aqueous dispersion. J. Contr. Rel. (2001) 77:1–6.
   Google Scholar
• SCHMIDGALL J, SCHNETZ E, HENSEL k Evidence for bioadhesive effects of polysaccharides and polysaccharide-containing herbs in an ex vivo bioadhesion assay on buccal membranes. Plant Medica (2000) 66:48–53.
   Google Scholar
• SHARON N: Lectin-carbohydrate complexes of plants and animals: an atomic view. Trends Biochem. Sci. (1993) 18:221–226.
   Google Scholar
• SMART JD: Lectin-mediated drug deliveryin the oral cavity. Adv. Drug Deliv. Revs. (2004) 56: 481–489.
   Google Scholar
• •A review of the use of lectins for drug delivery within the oral cavity.
   Google Scholar
• SMART JD, NANTWI PKK, ROGERS DJ, GREEN KL: A quantitative evaluation of radiolabelled lectin retention on oral mucosa in-vitro and in vivo. Europ. J. Pharm. Biopharm. (2002) 53: 289–292.
   Google Scholar
• HOOGSTRAATE JA, WERTZ PW: Drug delivery via the buccal mucosa. Pharm. Sci. Tech. Thday (1998) 1(7):309–316.
   Google Scholar
• BOTTENBURG P, CLAYMAET R et al.:Development and testing of bioadhesive fluoride-containing slow-release tablets for oral use. J. Pharm. Pharmacol (1991) 43:457–464.
   Google Scholar
• SMART JD, MORTAZAVI SA: An investigation of the pH within the hydrating gel layer of a poly (acrylic acid) compact. J. Pharm. Pharmac. (1995) 47:1099.
   Google Scholar
• SMART JD, BANCHONGLIKITKUL C, GIBBS RV, DONOVAN SJ, COOK DJ: Lectins in drug delivery to the oral cavity, in-vitro toxicity studies. STP Pharma Sci. (2003) 13:37–40.
   Google Scholar